Cargando…

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

Prevalence of different HPV genotypes is changing after HPV vaccination. The associated risks are needed for optimizing cervical cancer screening. To estimate HPV type-specific prevalence, odds ratio (OR), and positive predictive value (PPV) for cervical cytological abnormalities, we determined 41 d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nygård, Mari, Hansen, Bo T., Kjaer, Susanne K., Hortlund, Maria, Tryggvadóttir, Laufey, Munk, Christian, Lagheden, Camilla, Sigurdardottir, Lara G., Campbell, Suzanne, Liaw, Kai-Li, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018444/ https://www.ncbi.nlm.nih.gov/pubmed/32990181 http://dx.doi.org/10.1080/21645515.2020.1814097

Ejemplares similares

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
por: Nygård, Mari, et al.
Publicado: (2014)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia
por: Ku, Chun-Hoe, et al.
Publicado: (2014)

The Launch of an International Animal Papillomavirus Reference Center
por: Van Doorslaer, Koenraad, et al.
Publicado: (2019)

Metatranscriptome analysis in human papillomavirus negative cervical cancers
por: Ure, Agustin Enrique, et al.
Publicado: (2022)

Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants
por: Karadža, Magdalena, et al.
Publicado: (2021)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence
por: Iacobone, Anna Daniela, et al.
Publicado: (2021)

Progression Low Squamous Intraepithelial Lesion and Human Papillomavirus Infections
por: Jahic, Mahira, et al.
Publicado: (2020)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
por: Dillner, Joakim, et al.
Publicado: (2008)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
por: Lehtinen, Matti, et al.
Publicado: (2017)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

Human papillomavirus genotypes and HPV-16 variants distribution among Tunisian women with normal cytology and squamous intraepithelial lesions
por: Ghedira, R., et al.
Publicado: (2016)

Human papillomavirus genotypes and the risk factors associated with multicentric intraepithelial lesions of the lower genital tract: a retrospective study
por: Zhang, Jing, et al.
Publicado: (2021)

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
por: Lehtinen, Matti, et al.
Publicado: (2011)

Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis
por: Zhang, Junya, et al.
Publicado: (2020)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Human Papillomavirus Coinfection in the Cervical Intraepithelial Lesions and Cancer of Mexican Patients
por: Padilla-Mendoza, Juan Ramón, et al.
Publicado: (2020)

Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Sociodemographic Correlates of Human Papillomavirus Vaccine Uptake: Opportunistic and Catch-Up Vaccination in Norway
por: Dong, Li, et al.
Publicado: (2021)

Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
por: Louvanto, Karolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bn0snpfakcj2657ujtvnqsou9f